Header cover image

Polish Healthcare Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Scope Fluidics

Market Cap: zł463.4m

A biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland.

SCP

zł170.00

7D

11.1%

1Y

4.3%